ROY A. BEVERIDGE - 31 Mar 2022 Form 4 Insider Report for Epizyme, Inc.

Role: Director
Signature: /s/ John Weidenbruch, attorney-in-fact
Issuer symbol: N/A
Transactions as of: 31 Mar 2022
Net transactions value: +$13,125
Form type: 4
Filing time: 01 Apr 2022, 17:31:21 UTC
Previous filing: 18 Nov 2021
Next filing: 19 May 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	EPZM	Common Stock, par value $0.0001	Award	$13,125	+11,413	+68%	$1.15	28,115	31 Mar 2022	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The shares were issued to the Reporting Person pursuant to his election under the Issuer's director compensation program to receive such shares in lieu of cash fees of $13,125 for Board services for the first fiscal quarter of 2022. The shares were issued on the last day of the first fiscal quarter and the number of shares was calculated by dividing the cash fees to be paid for the quarter by the closing price of the Issuer's common stock on the last trading day of the quarter.

Content

The shares were issued to the Reporting Person pursuant to his election under the Issuer's director compensation program to receive such shares in lieu of cash fees of $13,125 for Board services for the first fiscal quarter of 2022. The shares were issued on the last day of the first fiscal quarter and the number of shares was calculated by dividing the cash fees to be paid for the quarter by the closing price of the Issuer's common stock on the last trading day of the quarter.